From Soup to NutsDrug Discovery & Development, April 01, 2008
Koronis Pharmaceuticals Appoints David Drajeske Director of Business DevelopmentPress Release, Koronis Pharmaceuticals, February 7, 2008
Why Are Evolutionary Biologists Bringing Back Extinct Deadly Viruses?The New Yorker, Annals of Science, Darwin’s Surprise, December 3, 2007
Koronis Pharmaceuticals develops anti-viral therapeutics based on Viral Decay Acceleration™™ (VDA). The Company's lead product candidate, KP-1461, is currently in clinical trials for HIV.
